Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 -0.0162550137217648 -0.0289212581802828
Stock impact report

FDA approves study of Alpha Tau's Alpha DaRT for recurrent cSCC treatment [Yahoo! Finance]

Alpha Tau Medical Ltd. - Ordinary Shares (DRTS) 
Company Research Source: Yahoo! Finance
Secondary efficacy objectives of the Alpha DaRT cancer therapy study will focus on progression-free survival, overall survival, and local control up to 12 months post-treatment. Additionally, the safety objective will involve monitoring any related adverse events. Alpha DaRT works by delivering highly potent alpha-irradiation directly into solid tumours using radium-224-impregnated sources. As the radium decays, its short-lived daughters are said to emit high-energy alpha particles for destroying the tumour. The limited diffusion of the alpha-emitting atoms is designed to primarily target the tumour while sparing surrounding healthy tissue. Alpha Tau Medical CEO Uzi Sofer said: “As we continue to progress in our ReSTART multicentre pivotal trial for recurrent cutaneous SCC, a number of investigators asked about the ability to treat immunocompromised patients, who are ineligible for the ReSTART trial. “Emory University is an important partner of ours and we are proud to wo Show less Read more
Impact Snapshot
Event Time:
DRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
DRTS alerts

from News Quantified
Opt-in for
DRTS alerts

from News Quantified